
The Alzheimer’s Association International Conference (AAIC) 2026 is underway in London, UK, marking a significant shift in dementia care. Researchers presented studies on blood-based biomarkers for Alzheimer’s disease, while experts debated the future of dementia business models.
Curated in the public interest from original reporting.
Read full story at NeurologyLive →
RELATED POSTS
View all
